Did we miss something? Our
COVID-19 Collection is growing, but not yet complete. Tell us what's missing. Email
contact@fairsharing.org or add missing resources to our
spreadsheet
iSpyBio
General Information
iSpyBio is an intelligent and unbiased search engine for Life scientists. It ranks reagents by the number of data such as publications, reviews, characterization images and tested applications. It displays over 500,000 reagents such as antibodies, proteins, ELISA kits and biomolecules. iSpyBio’s proprietary search algorithm is unique and rapidly analyzes the end-users search query against its large database. Powerful filters allow the user to enhance the search results, for example if they want a protein expressed in yeast or an antibody that only works in mouse. As iSpyBio syncs with supplier and other public databases, it is always up-to-date. This allows iSpyBio to exclude out of stock items but show the most recent testing results and peer-reviewed publications.
How to cite this record
FAIRsharing.org: iSpyBio; iSpyBio; DOI: https://doi.org/10.25504/FAIRsharing.17z0yf;
Last edited: Jan. 8, 2019, 1:20 p.m.; Last accessed: May 29 2020 1:41 a.m.
This record is maintained by
iSpyBio
Edits to 'https://fairsharing.org/FAIRsharing.17z0yf' by 'The FAIRsharing Team' at 07:21, 14 Dec 2016 (approved):
'contactName' has been modified:
Before:
Tillmann
After:
Tillmann Ziegert
Added:
Removed:
Access / Retrieve Data
Conditions of Use
Data Access
Publications
No publications available
Related Standards
Reporting Guidelines
No guidelines defined
Terminology Artifacts
No semantic standards defined
Models and Formats
No syntax standards defined
Identifier Schemas
No identifier schema standards defined
Metrics
No metrics standards defined
Related Databases
No related databases defined
Implementing Policies
This record is not implemented by any policy.
We need your help!
Do you have 5-10 minutes to help FAIRsharing prioritize future enhancements?
Then please fill out this short questionnaire to
prioritise the improvements that are of greatest importance to you.
Your views will help us choose which enhancements to provide first. Thank you very much!
